Effect of combination antiretroviral therapy on cytomegalovirus retinitis

Indian Journal of Ophthalmology

Volumn 50, Issue 1, 2002, Pages 29-33

  Banker, Alay S ^a   Patel, Atul ^b  

^a Banker's Retina Clinic and Laser Centre   (India)

^b Adit Medical Complex   (India)

Author keywords

Acquired immunodeficiency syndrome; Antiretroviral therapy; Cytomegalovirus retinitis; Immune recovery vitritis; Intravenous ganciclovir; Intravitreal cidofovir

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CIDOFOVIR; DIDANOSINE; GANCICLOVIR; HYDROXYUREA; INDINAVIR; LAMIVUDINE; NEVIRAPINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; IMMUNE RECOVERY VITRITIS; LYMPHOCYTE COUNT; MALE; RETINITIS; TREATMENT OUTCOME; VIRUS REACTIVATION; VITREOUS DISEASE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS RETINITIS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0036122154     PISSN: 03014738     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Jabs DA, Barlett JG. AIDS and ophthalmology: A period of transition. Am J Ophthalmol 1997;124:227-33.
2. Studies of Ocular Complications of AIDS (SOCA) Research Group, in collaboration with the AIDS Clinical Trials Group (ACTG). Mortality in patients with acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Eng J Med 1992;326:213-20.
3. Biswas JB, Joseph A, Raizada S, Kumarasamy N, Solomon S. Ophthalmic manifestations of human immunodeficiency virus (HIV) infection in India. Indian J Ophthalmol 1999;47:87-93.
4. Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, et al. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis. JAMA 1999;282:1633-37.
5. Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, ReedJB, Freeman WR. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis 1998;177:1182-87.
6. Macdonald CJ, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, et al. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Ophthalmology 2000;107:877-83.
7. Karavellas MP, Plummer DJ, Macdonald JC, Torriani FJ, Shufett CL, Azen SP, et al. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis 1999;179:697-700.
8. Nussenblatt RB, Palestine AG, Chan CC, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 1985;92:467-71.
9. Kirsch LS, Arevalo JF Chavez de la Paz E, Munguia D, de Clercq E, Freeman WR. Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1995;102:533-42.
10. Henderson HW, Mitchell SM. Treatment of immune recovery vitritis with local steroids. Br J Ophthalmol 1999;83:540-45.
11. Delta Coordinating Committee, Delta: A randomized double blind controlled trial comparing combinations of zidovudine plus didanosine or zulcitabine with zidovudine alone in HIV infected individuals. Lancet 1996;348:283-91.
12. Hammer SM, Katzenstein DA, Hughes MD, Gundaekar H, Schooley RT, Haubrich RH, et al. A trial comparing nucleoside monotherapy with combination therapy in HIV infected adults with CD4+ counts from 200 to 500 per cubic milliliter. N Eng J Med 1996;335:1081-90.
13. Collier AC, Coombs RW, Schoenfeld DA, Bassett RL, Timpone J, Baruch A, et al . Treatment of HIV infection with saquinavir, zidovudine, and zalcitabine. N Eng J Med 1996;334:1011-17.
14. Powderly WG. Prophylaxis for opportunistic infections in an era of effective antiretroviral therapy. Clin Infec Diseases 2000;31:597-601.
15. Karavellas MP, Azen SP, MacDonald JC, Shufeltn CL, Lowder CY, Plummer DJ, et al. Immune recovery vitritis and uveitis in AIDS: Clinical predictors, sequelae, and treatment outcomes. Retina 2001;21:1-9.
16. Beifort R Jr. The ophthalmologist and the global impact of the AIDS epidemic. 55th Edward Jackson Memorial Lecture. Am J Ophthalmol 2000;129:1-8.
17. HIV/AIDS: Indian scenario, National AIDS Control Organization, Ministry of Health and family affairs, Government of India. Surveillance for HIV/AIDS cases in India, August 2001. NACO website (http:// www.naco.nic.in).
18. Zambarakji HJ, Newson RB, Mitchell SM. CMVR diagnosis and progression of CD4 cell counts and HIV viral load measurements in HIV patients on HAART. Br J Ophthalmol 2001;85:837-41.